Notícias · Recifes

Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time

A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune cells to help tumors survive. Researchers say the findings, published in Biofabrication, reveal possible new targets to weaken the cancer's defenses and make

Admin Recifes 15/07/2026 2

Using AI to provide new insights into why Ebola outcomes differ between patients

There is currently a serious outbreak in the Democratic Republic of the Congo of the severe and often fatal illness. Symptoms include fever, vomiting, diarrhea, severe dehydration and hemorrhage. Rapid clinical deterioration is common. University of Liverpool researchers have led

Admin Recifes 15/07/2026 2

Researchers discover potential new treatment for Parkinson's disease, other neurodegenerat

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

Admin Recifes 15/07/2026 2

Researchers develop potential nonhormonal therapy to repair vaginal tissue damaged by meno

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM). GSM is a common chronic condition caused by declining estrogen levels that affects the vulva, vagina and urinary tra

Admin Recifes 15/07/2026 3

Drug candidate treats severe fatty liver disease by protecting the gut in animal models

Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.

Admin Recifes 15/07/2026 2

New approach could expand CAR T therapy from blood cancers to solid tumors

Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression in preclinical models of neuroblastoma, a rare and

Admin Recifes 15/07/2026 2

Get better sleep with ultrasound patch that boosts REM rest

A University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication. The technology, called NEUSLeeP, is a soft, wearable device that uses gentle ultrasound waves and electrodes to stim

Admin Recifes 15/07/2026 2

Clinical trial offers strong evidence that nerve blocks can cut opioid use after cardiac s

A clinical trial led by St. Michael's Hospital researchers found that using nerve blocks, an anesthesia technique to numb targeted areas of the body, significantly reduced opioid use after cardiac surgery—findings the authors say could reshape how the potentially addictive drugs

Admin Recifes 15/07/2026 2

Uptake of buprenorphine treatment for opioid use disorder is highly uneven across the Unit

There has been a substantial increase in recent years in the use of a form of primary medication to treat opioid use disorder, according to a Rutgers Health study published in Health Affairs. Researchers have also noted sharp differences in growth trends across the United States.

Admin Recifes 15/07/2026 2

Physical activity may help ease fatigue in children with developmental disabilities

Fatigue can be a daily challenge for children with developmental disabilities, affecting participation in school, play and other activities. In a new study by Virginia Tech researchers from the Fralin Biomedical Research Institute at VTC, parents reported that children who were m

Admin Recifes 15/07/2026 2

Novel antibody-drug conjugate eliminates residual cancer cells in majority of patients wit

Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival outcomes, by treating them with the antibody-drug conju

Admin Recifes 15/07/2026 2

Gene clues reveal why some rare leukemia patients resist tagraxofusp therapy

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-appro

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes